Exact Mass: 411.9804058

Exact Mass Matches: 411.9804058

Found 47 metabolites which its exact mass value is equals to given mass value 411.9804058, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

pyraflufen

Pyraflufen-ethyl

C15H13Cl2F3N2O4 (412.02044340000003)


CONFIDENCE standard compound; INTERNAL_ID 404; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9709; ORIGINAL_PRECURSOR_SCAN_NO 9708 CONFIDENCE standard compound; INTERNAL_ID 404; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9657; ORIGINAL_PRECURSOR_SCAN_NO 9655 CONFIDENCE standard compound; INTERNAL_ID 404; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9632; ORIGINAL_PRECURSOR_SCAN_NO 9630 CONFIDENCE standard compound; INTERNAL_ID 404; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9674; ORIGINAL_PRECURSOR_SCAN_NO 9672 CONFIDENCE standard compound; INTERNAL_ID 404; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9681; ORIGINAL_PRECURSOR_SCAN_NO 9679 CONFIDENCE standard compound; INTERNAL_ID 404; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9708; ORIGINAL_PRECURSOR_SCAN_NO 9706

   

dIDP

{[hydroxy({[(2R,3S,5R)-3-hydroxy-5-(6-oxo-6,9-dihydro-3H-purin-9-yl)oxolan-2-yl]methoxy})phosphoryl]oxy}phosphonic acid

C10H14N4O10P2 (412.0185164)


dIDP (deoxyinoside diphosphate) is a nucleoside. Deoxyinosine diphosphate appears in the urine of patients with purine metabolism abnormalities in purine nucleoside phosphorylase deficiency(OMIM 164050) [HMDB] dIDP (deoxyinoside diphosphate) is a nucleoside. Deoxyinosine diphosphate appears in the urine of patients with purine metabolism abnormalities in purine nucleoside phosphorylase deficiency(OMIM 164050).

   

Obtusol

C15-H23-Br2-Cl-O

C15H23Br2ClO (411.9804058)


   

1-(5-O-phosphono-beta-D-ribofuranosyl)-3,5-bis(sulfanylcarbonyl)pyridin-1-ium

1-(5-O-phosphono-beta-D-ribofuranosyl)-3,5-bis(sulfanylcarbonyl)pyridin-1-ium

C12H15NO9PS2+ (411.992585)


   

Thiamphenicol glycinate

N-{3-[(2-aminoacetyl)oxy]-1-hydroxy-1-(4-methanesulphonylphenyl)propan-2-yl}-2,2-dichloroethanimidic acid

C14H18Cl2N2O6S (412.02625880000005)


   

Opicapone

2,5-dichloro-3-[5-(3,4-dihydroxy-5-nitrophenyl)-1,2,4-oxadiazol-3-yl]-4,6-dimethylpyridin-1-ium-1-olate

C15H10Cl2N4O6 (411.997738)


D002491 - Central Nervous System Agents > D018726 - Anti-Dyskinesia Agents > D000978 - Antiparkinson Agents D004791 - Enzyme Inhibitors > D065098 - Catechol O-Methyltransferase Inhibitors N - Nervous system > N04 - Anti-parkinson drugs > N04B - Dopaminergic agents C78272 - Agent Affecting Nervous System > C38149 - Antiparkinsonian Agent

   
   
   
   

2,10-Dibromo-3-chloro-7(14)-chamigren-8-ol

2,10-Dibromo-3-chloro-7(14)-chamigren-8-ol

C15H23Br2ClO (411.9804058)


   

4,10-Dibromo-3-choloro-7,8-epoxychamigrane

4,10-Dibromo-3-choloro-7,8-epoxychamigrane

C15H23Br2ClO (411.9804058)


   
   

9-Hydroxy-4,10-dibromo-3-chloro-alpha-chamigrene

9-Hydroxy-4,10-dibromo-3-chloro-alpha-chamigrene

C15H23Br2ClO (411.9804058)


   

Quercetagetin 3-methyl ether 7-O-sulfate

Quercetagetin 3-methyl ether 7-O-sulfate

C16H12O11S (412.0100322)


   

Patuletin 7-O-sulfate

3,5,7,3,4-Pentahydroxy-6-methoxyflavon 7-O-sulfate

C16H12O11S (412.0100322)


   
   
   
   

Patuletin 3-O-sulfate

Patuletin 3-O-sulfate

C16H12O11S (412.0100322)


   
   

14,14-dibromo-6,7-dihydroxytetradeca-4,13-dienoic acid|xestospongiene R

14,14-dibromo-6,7-dihydroxytetradeca-4,13-dienoic acid|xestospongiene R

C14H22Br2O4 (411.9884732)


   

ethyl (3,5-dibromo-4-ethoxy-1-hydroxy-4-methoxycyclohexa-2,5-dien-1-yl)acetate

ethyl (3,5-dibromo-4-ethoxy-1-hydroxy-4-methoxycyclohexa-2,5-dien-1-yl)acetate

C13H18Br2O5 (411.9520898)


   

LEOIDIN

NCGC00095464-02!LEOIDIN

C18H14Cl2O7 (412.0116554)


   
   

dichloropalladium,triethylphosphane

dichloropalladium,triethylphosphane

C12H30Cl2P2Pd (412.023445)


   

1h,1h,9h,9h-perfluoro-1,9-nonanediol

1h,1h,9h,9h-perfluoro-1,9-nonanediol

C9H6F14O2 (412.0144224)


   

1H,1H,1H-PENTADECAFLUORO-2-NONANONE

1H,1H,1H-PENTADECAFLUORO-2-NONANONE

C9H3F15O (411.9944368)


   

Methyl 5-iodo-2-(2-(methoxycarbonyl)phenoxy)benzoate

Methyl 5-iodo-2-(2-(methoxycarbonyl)phenoxy)benzoate

C16H13IO5 (411.9807718)


   

barium(2+),2-carboxyphenolate

barium(2+),2-carboxyphenolate

C14H10BaO6 (411.952972)


   

Ambroxol HCl

cis-4-[(2-Amino-3,5-dibromobenzyl)amino]cyclohexanol hydrochloride (1:1)

C13H19Br2ClN2O (411.9552554)


C78273 - Agent Affecting Respiratory System > C74536 - Mucolytic Agent D019141 - Respiratory System Agents > D005100 - Expectorants

   
   

Benzenesulfonamide,N-(3-bromopropyl)-4-methyl-N-(4-nitrophenyl)-

Benzenesulfonamide,N-(3-bromopropyl)-4-methyl-N-(4-nitrophenyl)-

C16H17BrN2O4S (412.00923420000004)


   

diisopropylbis(trifluoromethanesulfonyl)silane

diisopropylbis(trifluoromethanesulfonyl)silane

C8H14F6O6S2Si (411.99052559999996)


   

thallium(i) hexafluoroacetylacetonate

thallium(i) hexafluoroacetylacetonate

C5HF6O2Tl (411.9624838)


   

thiamphenicol

Thiamphenicol glycinate

C14H18Cl2N2O6S (412.02625880000005)


   

Perfluoro-3,6,9-trioxadecanoic acid

Perfluoro-3,6,9-trioxadecanoic acid

C7HF13O5 (411.9616412)


   

ethyl 6-broMo-1,5-diMethyl-2-(2-nitroethyl)-1H-indole-3-carboxylate coMpound with Methanedione (1:1)

ethyl 6-broMo-1,5-diMethyl-2-(2-nitroethyl)-1H-indole-3-carboxylate coMpound with Methanedione (1:1)

C16H17BrN2O6 (412.0269922)


   
   

2-(2,2-Dichloroacetamido)-3-hydroxy-3-[4-(methanesulfonyl)phenyl]propyl glycinate

2-(2,2-Dichloroacetamido)-3-hydroxy-3-[4-(methanesulfonyl)phenyl]propyl glycinate

C14H18Cl2N2O6S (412.02625880000005)


   

1-Perfluoromethylcyclohexane-1-sulfonic acid

1-Perfluoromethylcyclohexane-1-sulfonic acid

C7HF13O3S (411.94388319999996)


   

5-Bromo-3-[[(5-methyl-1,3,4-thiadiazol-2-yl)thio]methyl]-2-benzofurancarboxylic acid ethyl ester

5-Bromo-3-[[(5-methyl-1,3,4-thiadiazol-2-yl)thio]methyl]-2-benzofurancarboxylic acid ethyl ester

C15H13BrN2O3S2 (411.95509280000005)


   

(3S,4R,6R,9R,10R)-4,9-Dibromo-10-chloro-5,5,9-trimethyl-1-methylidenespiro[5.5]undecan-3-ol

(3S,4R,6R,9R,10R)-4,9-Dibromo-10-chloro-5,5,9-trimethyl-1-methylidenespiro[5.5]undecan-3-ol

C15H23Br2ClO (411.9804058)


   

[2-Hydroxy-5-(3,5,7-trihydroxy-6-methoxy-4-oxochromen-2-yl)phenyl] hydrogen sulate

[2-Hydroxy-5-(3,5,7-trihydroxy-6-methoxy-4-oxochromen-2-yl)phenyl] hydrogen sulate

C16H12O11S (412.0100322)


   

2-Deoxyinosine-5-diphosphate

2-Deoxyinosine-5-diphosphate

C10H14N4O10P2 (412.0185164)


A deoxyinosine phosphate compound having a diphosphate group at the 5-position.

   

Opicapone

Opicapone

C15H10Cl2N4O6 (411.997738)


D002491 - Central Nervous System Agents > D018726 - Anti-Dyskinesia Agents > D000978 - Antiparkinson Agents D004791 - Enzyme Inhibitors > D065098 - Catechol O-Methyltransferase Inhibitors N - Nervous system > N04 - Anti-parkinson drugs > N04B - Dopaminergic agents C78272 - Agent Affecting Nervous System > C38149 - Antiparkinsonian Agent